Florida International University (FIU) is pursuing a commercial partner interested in developing Novel Silicone Nanoparticles. Investigators at FIU designed and tested novel silicone nanoparticles that can provide a significant advantage compared to silicone microparticles. The silicone nanoparticles can be engineered to elude the body’s immune recognition and avoid subsequent silicone related toxicity and adverse effects.
- Breast Implants
- Reconstructive Mammoplasty
- Cosmetic and Plastic Surgery
- Bypasses the immune system and causes less inflammation and adverse immune responses.
- Provides a safer alternative for silicone use in patients and in devices.
Silicone nanoparticles do not induce immune responses by na’ve human peripheral blood mononuclear cells: implications in breast implants.
Plast Reconstr Surg. 2012 Jul;130(1):128e-137e.
Nair N, Pilakka-Kanthikeel S, Saiyed Z, Yndart A, Nair M.
For additional information about this technology opportunity, please contact Elizabeth Garami at email@example.com or by phone at 305-348-0008 and ask about record IP 1204.